Personalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular Carcinoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Personalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular Carcinoma	Advanced Hepatocellular Carcinoma (HCC)	Recruiting	Phase 1 / Phase 2	2025-05-29		NCT06995105

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Hangzhou Neoantigen Therapeutics Co., Ltd.	11
Zhejiang University	194

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The first Affiliated Hospital, Zhejiang University School of Medicine	Hangzhou	China	69

Clinical trials